Skip to NavigationSkip to content

News

0
Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the Angecy regarding its biosimilar for...
0
Novartis has revealed that its drug Tafinlar (dabrafenib) has received approval from the FDA for use in combination with Mekinist (trametinib) in...
0
For the first time in English history, new diagnoses of HIV have fallen across the country – the drop was steepest in areas where HIV testing was...
0
4.3 million people in the EU are affected by rare cancers, and an estimated 500,000 new cases are diagnosed annually; Dr Terese Johansson highlights...

Features

Pharmafocus caught up with Lawrence Blatt, Janssen’s Global Therapeutic Area Head, Infectious Diseases and Vaccines, to discuss...